The K@W Network:
Legislators in Washington are up in arms over a wave of companies pursuing overseas acquisitions so they can escape high U.S. taxes. But can the capital flight be stopped?
Better models of care will go a long way toward spurring health care providers to make better choices between increased costs and improved outcomes, Wharton's Mark Pauly writes.
Tobacco firm Reynolds American’s $27.4 billion bid to buy competitor Lorillard has raised antitrust concerns. What will the deal mean for the industry and tobacco users?
In the midst of an M&A frenzy in the global pharmaceutical industry, Wharton experts advise companies to keep a watchful eye on runaway valuations and post-merger integration.